Tscan therapeutics reports third quarter 2023 financial results and provides corporate update

Company to present poster on initial data from heme malignancies phase 1 trial at the 65 th ash annual meeting and exposition; company to host virtual kol event on monday, december 11, 2023, at 8:00 a.m. et
TCRX Ratings Summary
TCRX Quant Ranking